|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/4375 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3277681 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16717560.3 |
| Date of filing the European patent application | 2016-03-31 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (86) | Number | PCT/EP2016/000542 |
| Date | 2016-03-31 |
| (87) | Number | WO 2016/155884 |
| Date | 2016-10-06 |
| (30) | Number | Date | Country code |
| 15000968 | 2015-04-02 | EP |
| (72) |
FUCHSS, Thomas, DE
SCHIEMANN, Kai, DE
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazolonilchinolinai ir jų panaudojimas, kaip ATM kinazės inhibitorių |
| IMIDAZOLONYLQUINOLINES AND THEIR USE AS ATM KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 11 | 289.00 EUR |
| 2027-03-31 |